DK0891371T3 - 9-oximsilylerythromycin A derivater - Google Patents
9-oximsilylerythromycin A derivaterInfo
- Publication number
- DK0891371T3 DK0891371T3 DK97905826T DK97905826T DK0891371T3 DK 0891371 T3 DK0891371 T3 DK 0891371T3 DK 97905826 T DK97905826 T DK 97905826T DK 97905826 T DK97905826 T DK 97905826T DK 0891371 T3 DK0891371 T3 DK 0891371T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivatives
- silylerythromycin
- oxime
- alkylerythromycin
- oximesilyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/626,524 US5837829A (en) | 1996-04-02 | 1996-04-02 | 9-oximesilyl erythromycin a derivatives |
PCT/US1997/001955 WO1997036913A1 (en) | 1996-04-02 | 1997-02-06 | 9-oximesilyl erythromycin a derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0891371T3 true DK0891371T3 (da) | 2004-04-13 |
Family
ID=24510750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97905826T DK0891371T3 (da) | 1996-04-02 | 1997-02-06 | 9-oximsilylerythromycin A derivater |
Country Status (10)
Country | Link |
---|---|
US (1) | US5837829A (ja) |
EP (1) | EP0891371B1 (ja) |
JP (2) | JP2000507574A (ja) |
AT (1) | ATE256138T1 (ja) |
CA (1) | CA2250771C (ja) |
DE (1) | DE69726714T2 (ja) |
DK (1) | DK0891371T3 (ja) |
ES (1) | ES2212808T3 (ja) |
PT (1) | PT891371E (ja) |
WO (1) | WO1997036913A1 (ja) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2173057T3 (es) | 1996-07-29 | 2004-11-16 | Abbott Laboratories | Preparacion de la forma ii cristalina de claritromicina. |
US5858986A (en) | 1996-07-29 | 1999-01-12 | Abbott Laboratories | Crystal form I of clarithromycin |
US5945405A (en) | 1997-01-17 | 1999-08-31 | Abbott Laboratories | Crystal form O of clarithromycin |
US20080050367A1 (en) | 1998-04-07 | 2008-02-28 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
WO1999032500A2 (en) * | 1997-12-22 | 1999-07-01 | Biochemie S.A. | Intermediates in macrolide production |
KR100283990B1 (ko) * | 1998-12-29 | 2001-03-02 | 민경윤 | 에리스로마이신 a 유도체 및 그의 제조방법 |
US6437106B1 (en) | 1999-06-24 | 2002-08-20 | Abbott Laboratories | Process for preparing 6-o-substituted erythromycin derivatives |
GB9915745D0 (en) * | 1999-07-06 | 1999-09-08 | Biochemie Sa | Organic compounds |
IL150227A0 (en) * | 1999-12-16 | 2002-12-01 | Teva Pharma | Processes for preparing clarithromycin polymorphs and novel polymorph iv |
KR20020071012A (ko) | 2000-01-11 | 2002-09-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 클래리스로마이신 다형체의 제조 방법 |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
PL366021A1 (en) * | 2000-02-29 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
KR100367981B1 (ko) * | 2000-11-23 | 2003-01-14 | 한미약품공업 주식회사 | 클라리스로마이신 결정형 2의 제조 방법 및 이 방법에사용되는 결정성 클라리스로마이신 메실레이트 삼수화물 |
CN1193036C (zh) * | 2000-03-15 | 2005-03-16 | 韩美药品工业株式会社 | 制备甲红霉素-克拉霉素ⅱ型晶体的方法 |
US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
WO2005009364A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009365A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009368A2 (en) | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005016311A1 (en) | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
WO2005027877A1 (en) | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2006014427A1 (en) | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US20060111560A1 (en) * | 2004-11-01 | 2006-05-25 | Glenmark Pharmaceuticals Limited | Process for the preparation of crystalline form II of clarithromycin |
US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8784810B2 (en) | 2006-04-18 | 2014-07-22 | Janssen Alzheimer Immunotherapy | Treatment of amyloidogenic diseases |
WO2009017467A1 (en) | 2007-07-27 | 2009-02-05 | Elan Pharma International Limited | Treatment of amyloidogenic diseases |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
US20090054634A1 (en) * | 2007-08-09 | 2009-02-26 | Vinod Kumar Kansal | Process for the preparation of clarithromycin |
JO3076B1 (ar) | 2007-10-17 | 2017-03-15 | Janssen Alzheimer Immunotherap | نظم العلاج المناعي المعتمد على حالة apoe |
US9067981B1 (en) | 2008-10-30 | 2015-06-30 | Janssen Sciences Ireland Uc | Hybrid amyloid-beta antibodies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4670549A (en) * | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
US4640910A (en) * | 1985-11-12 | 1987-02-03 | Abbott Laboratories | Erythromycin A silylated compounds and method of use |
DE3782994T2 (de) * | 1986-09-18 | 1993-04-08 | Taisho Pharma Co Ltd | Erythromycin-a-derivate und verfahren zu ihrer herstellung. |
KR960000434B1 (ko) * | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
-
1996
- 1996-04-02 US US08/626,524 patent/US5837829A/en not_active Expired - Lifetime
-
1997
- 1997-02-06 DE DE69726714T patent/DE69726714T2/de not_active Expired - Fee Related
- 1997-02-06 CA CA002250771A patent/CA2250771C/en not_active Expired - Fee Related
- 1997-02-06 AT AT97905826T patent/ATE256138T1/de not_active IP Right Cessation
- 1997-02-06 WO PCT/US1997/001955 patent/WO1997036913A1/en active IP Right Grant
- 1997-02-06 EP EP97905826A patent/EP0891371B1/en not_active Expired - Lifetime
- 1997-02-06 PT PT97905826T patent/PT891371E/pt unknown
- 1997-02-06 DK DK97905826T patent/DK0891371T3/da active
- 1997-02-06 JP JP9535252A patent/JP2000507574A/ja not_active Withdrawn
- 1997-02-06 ES ES97905826T patent/ES2212808T3/es not_active Expired - Lifetime
-
2007
- 2007-04-06 JP JP2007100369A patent/JP2007224035A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69726714T2 (de) | 2004-10-07 |
EP0891371B1 (en) | 2003-12-10 |
CA2250771C (en) | 2006-05-02 |
JP2007224035A (ja) | 2007-09-06 |
EP0891371A1 (en) | 1999-01-20 |
PT891371E (pt) | 2004-04-30 |
JP2000507574A (ja) | 2000-06-20 |
WO1997036913A1 (en) | 1997-10-09 |
US5837829A (en) | 1998-11-17 |
ATE256138T1 (de) | 2003-12-15 |
DE69726714D1 (en) | 2004-01-22 |
ES2212808T3 (es) | 2004-08-01 |
CA2250771A1 (en) | 1997-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0891371T3 (da) | 9-oximsilylerythromycin A derivater | |
ES2191982T3 (es) | Derivados de 6-o-alquilo de eritronolida b. | |
AU7596587A (en) | Benzimidazole derivatives | |
ES2191821T3 (es) | Procedimiento de preparacion de oxima de eritromicina a. | |
AU6853987A (en) | Produce hydration system | |
FR2647661B1 (fr) | Tomodensitometre double tranche | |
TR199500917A2 (tr) | Iiia grubunun organometalik türevleri ve bunlarin hazirlanisi icin bir islem. | |
PT1042340E (pt) | Oxima de 6-o-alquil-eritromicina b | |
AU7067087A (en) | Improved process for preparing macrolide derivatives | |
AU6867487A (en) | Benzimidazole derivatives | |
NO901070L (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
TR23145A (tr) | Diflufenican kullanan herbisidal usul | |
DK555289A (da) | Fermenteringsfremgangsmaade | |
AU7703887A (en) | Tube expander | |
DK445188A (da) | Vandoploeseligt antibiotisk praeparat | |
KR970702922A (ko) | 독소루비신의 제조방법(Process for preparing doxorubicin) | |
AU8204887A (en) | Conjugate vaccine | |
AU7216287A (en) | Benzimidazole derivatives | |
NO901071D0 (no) | Fremgangsmaate for fremstilling av tieno-triazolo-diazepin-derivater. | |
DE3888529D1 (de) | Tylosinderivate und Verfahren zu ihrer Herstellung. | |
AU3665289A (en) | Polysilazanes, process for their preparation | |
AU6679490A (en) | Dye couplers | |
NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
NO890216D0 (no) | Fremgangsmaate for revitalisering av forstkulturer. | |
IE893449L (en) | Tylosin derivatives |